通產麗星(002243.SZ):創新發展斥2750萬元設立控股子公司
格隆匯3月9日丨通產麗星(002243.SZ)公佈,公司的全資孫公司深圳力合創新發展有限公司(“創新發展”)根據發展規劃和經營需要,以自有資金出資設立控股子公司力合沙井科技創新基地(深圳)有限責任公司(“新公司”或“力合沙井”),註冊資本為人民幣5000萬元,創新發展認繳出資人民幣2750萬元,佔註冊資本的55%。上述事項已按相關規定履行了審批手續,相關國資主管機構也出具了同意批覆。近日,力合沙井已取得了深圳市市場監督管理局頒發的營業執照。
力合沙井科技創新基地(深圳)有限責任公司經營範圍:自有物業租賃;科技園區、孵化基地投資、開發和建設;投資興辦實業(具體項目另行申報)。
此次設立新公司有利於進一步擴展公司的經營區域,提升公司核心競爭力和盈利能力,對公司未來發展具有積極意義和推動作用,符合全體股東利益和公司長遠發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.